System and method to modulate phrenic nerve to prevent sleep apnea
US10518090B2 · kind B2 · utility
5Cited by
53References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 29, 2012 |
| Grant date | Dec 31, 2019 |
| Priority date | — |
| Expiry date | Jun 29, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/3615
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
An implantable medical device for treating breathing disorders such as central sleep apnea wherein stimulation is provided to the phrenic never through a transvenous lead system with the stimulation beginning after inspiration to extend the duration of a breath and to hold the diaphragm in a contracted condition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.